resprotect.de bewertung und analyse
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | RESprotect - Prevention of Chemoresistance - Welcome to |
| Description | RESprotect - Drugs for the Prevention of |
| Keywords | hsp27, cancer, prevention, rp101, Chemoresistance, chemotherapy, chemo, resistance, drugs, medicine, Chemoresistenz, RESprotect,Medikamente, Chemo, resistenzverhinderung, Krebs, Pharma, Krebstherapie, Forschung, Medizin |
Server Information
| WebSite | |
| Host IP | 144.76.220.122 |
| Location | Germany |
Verwandte Websites
| Site | Rank |
| ligro-gmbh.de | 0 |
| gentgmbh.de | 0 |
| schumann-gmbh.de | 15,037,436 |
| bwb-gmbh.de | 3,372,365 |
| vector-gmbh.de | 0 |
Mehr zu entdecken
resprotect.de bewertung
|
Euro€1,102
Zuletzt aktualisiert: 2022-07-22 17:23:55
resprotect.de hat Semrush globalen Rang von 36,214,636. resprotect.de hat einen geschätzten Wert von € 1,102, basierend auf seinen geschätzten Werbeeinnahmen. resprotect.de empfängt jeden Tag ungefähr 551 einzelne Besucher. Sein Webserver befindet sich in Germany mit der IP-Adresse 144.76.220.122. Laut SiteAdvisor ist resprotect.de sicher zu besuchen. |
Verkehr & Wertschätzungen
| Kauf-/Verkaufswert | Euro€1,102 |
| Tägliche Werbeeinnahmen | Euro€22,040 |
| Monatlicher Anzeigenumsatz | Euro€7,714 |
| Jährliche Werbeeinnahmen | Euro€551 |
| Tägliche eindeutige Besucher | 551 |
| Hinweis: Alle Traffic- und Einnahmenwerte sind Schätzungen. | |
DNS Records
| Host | Type | TTL | Data |
| resprotect.de. | A | 86400 | IP: 144.76.220.122 |
| resprotect.de. | NS | 86400 | NS Record: ns1.first-ns.de. |
| resprotect.de. | NS | 86400 | NS Record: robotns3.second-ns.com. |
| resprotect.de. | NS | 86400 | NS Record: robotns2.second-ns.de. |
| resprotect.de. | MX | 86400 | MX Record: 10 mail.infoworks.de. |
| resprotect.de. | TXT | 86400 | TXT Record: MS=ms22897429 |
HtmlToTextCheckTime:2022-07-22 17:23:55
| Saturday, 16 November 2013 Contact Us Search Home About us Corporate Overview History Management Team Advisory Boards Partnering & Licensing Contact Contact Us Impressum News Current News Current Publications News Archive 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 Publications Archive RESprotect Publications Other relevant Publications Newsletter Chemogenomics Product Portfolio Pipeline Summary RP101 RP101 Inhibition Hsp27 Key Effects Interaction Hsp27 Suppression Pancreatic Cancer The Role of Hsp27 Clinical Effects of RP101 Summary of Clinical Trials Competitive Advantage 2nd Generation Fraunhofer-Award Two times winner of the Joseph-von-Fraunhofer Award Other Awards RESprotect is winner of the futureSAX award 2007 RESprotect is winner of the IQ innovation award Central Germany 2005 Welcome to RESprotect RESprotect GmbH is a Dresden based, privately held Biotech company specialising in the development of drugs for the prevention and treatment of |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx Date: Fri, 22 Jul 2022 08:55:33 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://resprotect.de/ HTTP/2 200 server: nginx date: Fri, 22 Jul 2022 08:55:34 GMT content-type: text/html content-length: 26357 x-accel-version: 0.01 last-modified: Sat, 16 Nov 2013 16:58:52 GMT etag: "66f5-4eb4e3ab8ab00" accept-ranges: bytes x-powered-by: PleskLin |